Yuhan Corporation and InventiGelab Begin Joint Development of CBD-Based Long‑Acting Injectable

Yuhan Corporation and InventiGelab are jointly developing a CBD‑based long‑acting injectable formulation. The project is being led by Yuhan’s consumer health division and is focused on significantly improving dosing convenience compared with existing oral formulations. The collaboration is notable because a major domestic pharmaceutical company is directly participating in the development of a CBD medicine.

For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.